Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Latanoprost can effectively treat eyelash hair loss, with 45% of patients showing hair regrowth and no reported side effects.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

New alopecia treatments aim for better results and fewer side effects.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Late pregnancy helps repair brain damage in rats due to the GABAergic system.

SVF-enhanced adipose transplantation shows potential as a hair loss treatment.

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Thyroid hormone may speed up wound healing and hair growth, but more research is needed to understand its role in skin repair and use as a treatment.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.